Top 10 drugs to watch
March 20, 2013 12:25 PM
Tricor
Used for: high cholesterol
Manufactured by: Abbott
Estimated annual sales: $1.3 billion
Generic approved: November 2012
Seroquel
Used for: schizophrenia, bipolar disorder
Manufactured by: AstraZeneca
Estimated annual sales: $4.6 billion
Generic approved: March 2012
Plavix
Used for: Preventing blood clots after a stroke or heart attack
Manufactured by: Bristol Myers Squibb/Sanofi
Estimated annual sales: $6.7 billion
Generic approved: May 2012
Singulair
Used for: asthma
Manufactured by: Merck
Estimated annual sales: $4.6 billion
Generic approved: August 2012
Actos
Used for: type 2 diabetes
Manufactured by: Takeda
Estimated annual sales: $3.4 billion
Generic approved: August 2012
Avapro/Avalide
Used for: high blood pressure
Manufactured by: Bristol Myers Squibb/Sanofi
Estimated annual sales: $591 million
Generic approved: March 2012
Lexapro
Used for: depression, anxiety disorder
Manufactured by: Forest Laboratories
Estimated annual sales: $2.9 billion
Generic approved: March 2012
Boniva
Used for: osteoporosis
Manufactured by: Genentech
Estimated annual sales: $510 million
Generic approved: March 2012
Provigil
Used for: Improves wakefulness in adults who experience excessive sleepiness due to obstructive sleep apnea, shift work sleep disorder or narcolepsy
Manufactured by: Teva
Estimated annual sales: $1.1 billion
Generic approval: April 2012
Diovan
Used for: high blood pressure
Manufactured by: Novartis
Estimated annual sales: $3.6 billion
Generic approval: September 2012
